[ad_1]
A volunteer receives Moderna vaccine in a clinical trial – Henry Ford Health System / AFP / Archives
The modern pharmaceutical company informed the press that its experimental vaccine was 94.5% effective in preventing COVID-19. The 30,000 volunteers who participated in phase 3 of the trials reported no relevant side effects. The study has not yet been reviewed or published in a scientific journal.
“This is a crucial moment in the development of our COVID-19 candidate vaccine. Since the beginning of January, we have been pursuing this virus with the intention of protecting as many people as possible around the world. All the time, we know that every day is important. This positive interim analysis of our phase 3 study gave us the first clinical validation that our vaccine can prevent COVID-19 disease, including serious diseases, ”said Stéphane Bancel, CEO of Moderna, in the press release.
According to the statement, 95 people contracted the coronavirus: five were vaccinated with mRNA-1273 and 90 received placebo injections. Statistically, the difference between the two groups was very significant. Of the 95 cases, 11 were severe, all in the placebo group.
“The preliminary analysis suggests a safety and efficacy profile that is broadly consistent across all subgroups evaluated,” says the company. Also according to Moderna, its immunizing potential for coronavirus has a shelf life of 30 days even if it is kept in conventional refrigerators.
In the coming weeks, the drugmaker said it plans to apply to the United States Food and Drug Administration (FDA) for authorization for emergency use of the vaccine.
Moderna is the second vaccine produced in the United States to reveal the results of the third phase of testing. Last Monday (9), Pfizer and BioNTech announced that the experimental vaccine they jointly developed proved to be 90% effective in preventing coronavirus, according to preliminary data from the third phase of clinical studies.
It’s worth mentioning that vaccine experts caution that these numbers are not fixed. The estimates may go up or down as the respective trials continue, and ultimately the vaccines may be shown to work better in some groups than others.
see also
+ The trick to squeeze lemons becomes crazy on social networks
+ Woman pretends to be an FBI agent to get free food and goes to jail
+ MasterChef: Fogaça compares plate with dog food
+ The Digital Blue Zone in SP changes on the 16th; look how it looks
+ See the best-selling cars in October
+ The humpback whale almost swallowed two women in kayaks; watch the video
+ Meet the phloeodes diabolicus “the indestructible beetle”
+ Study reveals the healthiest method of cooking rice
+ 10 things parents do in public that embarrass their children
+ Can burping a lot be a health problem?
+ Shark is captured in MA with remains of missing youths in stomach
+ Cinema, sex and the city
+ A 6,500-year-old copper workshop discovered in the desert of Israel
[ad_2]
